Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR3 | P32745 | 1/20 | 0.53 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.31 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.31 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1639849 | 1.00 | SSTR3 (0.53) | SSTR3SIGMAR1KDM4EALDH1A1MAPT | |
| SCHEMBL21800086 | 0.86 | SSTR3 (0.43) | SSTR3SIGMAR1 | |
| SCHEMBL13912964 | 0.81 | RAD52 (0.41) | SSTR3SIGMAR1KDM4EALDH1A1DPP4 | |
| SCHEMBL12155818 | 0.80 | SSTR3 (0.52) | SSTR3SIGMAR1KDM4EALDH1A1MAPT | |
| SCHEMBL3645463 | 0.79 | RAD52 (0.44) | SSTR3SIGMAR1KDM4EALDH1A1 | |
| SCHEMBL12156771 | 0.76 | RAD52 (0.37) | SSTR3KDM4EALDH1A1DPP4S1PR1 | |
| SCHEMBL4487986 | 0.76 | SSTR3 (0.46) | SSTR3SIGMAR1KDM4EALDH1A1MAPT | |
| SCHEMBL4501704 | 0.76 | SSTR3 (0.46) | SSTR3SIGMAR1KDM4EALDH1A1MAPT | |
| SCHEMBL4501706 | 0.76 | SSTR3 (0.46) | SSTR3SIGMAR1KDM4EALDH1A1MAPT | |
| SCHEMBL4487988 | 0.76 | SSTR3 (0.46) | SSTR3SIGMAR1KDM4EALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7794917-B2 | Curable composition, color filter and manufacturing method thereof | FUJIFILM CORPORATION (JP) | 2010-09-14 | — | — | US | disclosed |
| US-7517895-B2 | Synthetic diazonamides | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2009-04-14 | — | — | US | disclosed |
| US-20080076043-A1 | CURABLE COMPOSITION, COLOR FILTER AND MANUFACTURING METHOD THEREOF | FUJIFILM CORPORATION (JP) | 2008-03-27 | — | — | US | disclosed |
| US-20060089397-A1 | Synthetic diazonamides | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2006-04-27 | — | — | US | disclosed |
| US-7022720-B2 | Synthetic diazonamides as novel anti-mitotic agents | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2006-04-04 | — | — | US | disclosed |
| US-20030100589-A1 | Synthetic diazonamides as novel anti-mitotic agents | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2003-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060089397-A1 | Synthetic diazonamides | BUB1B, BUB1, CDK15 | SSTR3 733/4885SIGMAR1 4130/4885KDM4E 1149/4885 |
| US-20030100589-A1 | Synthetic diazonamides as novel anti-mitotic agents | BUB1B, BUB1, BUB3 | SSTR3 860/4885SIGMAR1 3679/4885KDM4E 1469/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.